The Latest Breaking News from Clinical Trial

In a world first clinical trial, red blood cells that were grown in a laboratory have been transfused into two people.

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Scientists say that if proved safe, manufactured blood cells could revolutionise treatments for people with blood disorders

Two successful clinical trials of lab-grown red blood cells could revolutionise treatments for people with rare blood types amid an NHS shortage

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).

Vancouver-based psychedelics biopharma company Apex Labs Ltd.

Researchers at Imperial College London, University College London and Imperial College Healthcare NHS Trust have found that a new type of ultrasound scan can diagnose most prostate cancer cases with good accuracy in a clinical trial involving 370 men. Read on for details:

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.